Juanping Zhao Selected Research

ASPER-29

1/2023	Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
2/2022	ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juanping Zhao Research Topics

Disease

3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 02/2022
2	Neoplasm Metastasis (Metastasis) 03/2024 - 02/2022
2	Neoplasms (Cancer) 01/2023 - 02/2022

Drug/Important Bio-Agent (IBA)

2	Cathepsin LIBA 01/2023 - 02/2022
2	asperphenamateIBA 01/2023 - 02/2022
2	ASPER-29IBA 01/2023 - 02/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 03/2024
1	cathepsin SIBA 02/2022
1	CathepsinsIBA 02/2022
1	4-boronic acid benzophenoneIBA 02/2022

Therapy/Procedure

1	Therapeutics 01/2023